DAFNA Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.01M | Buy |
|
|||||
|
2025
Q1 | $9.18M | Hold |
|
|||||
|
2024
Q4 | $10.7M | Hold |
|
|||||
|
2024
Q3 | $10.8M | Hold |
|
|||||
|
2024
Q2 | $10.7M | Hold |
|
|||||
|
2024
Q1 | $11.8M | Sell |
|
|||||
|
2023
Q4 | $12.7M | Sell |
|
|||||
|
2023
Q3 | $9.58M | Hold |
|
|||||
|
2023
Q2 | $10.8M | Sell |
|
|||||
|
2023
Q1 | $11.3M | Hold |
|
|||||
|
2022
Q4 | $12.5M | Sell |
|
|||||
|
2022
Q3 | $13.5M | Sell |
|
|||||
|
2022
Q2 | $13.3M | Buy |
|
|||||
|
2022
Q1 | $11.6M | Sell |
|
|||||
|
2021
Q4 | $12.6M | Sell |
|
|||||
|
2021
Q3 | $6.21M | Hold |
|
|||||
|
2021
Q2 | $7.57M | Hold |
|
|||||
|
2021
Q1 | $7.28M | Buy |
|
|||||
|
2020
Q4 | $5.33M | Hold |
|
|||||
|
2020
Q3 | $3.84M | Hold |
|
|||||
|
2020
Q2 | $4.35M | Hold |
|
|||||
|
2020
Q1 | $3.93M | Buy |
|
|||||
|
2019
Q4 | $3.26M | Sell |
|
|||||
|
2019
Q3 | $2.98M | Hold |
|
|||||
|
2019
Q2 | $3.26M | Hold |
|
|||||
|
2019
Q1 | $3.36M | Buy |
|
|||||
|
2018
Q4 | $1.5M | Hold |
|
|||||
|
2018
Q3 | $3.14M | Sell |
|
|||||
|
2018
Q2 | $2.71M | Sell |
|
|||||
|
2018
Q1 | $1.85M | Hold |
|
|||||
|
2017
Q4 | $1.07M | Hold |
|
|||||
|
2017
Q3 | $1.11M | Hold |
|
|||||
|
2017
Q2 | $1.19M | Buy |
|
|||||
|
2017
Q1 | $1.36M | Sell |
|
|||||
|
2016
Q4 | $3.96M | Hold |
|
|||||
|
2016
Q3 | $4.16M | Buy |
|
|||||
|
2016
Q2 | $1.26M | Buy |
|
|||||
|
2016
Q1 | $1.35M | Buy |
|
|||||
|
2015
Q4 | $786K | Buy |
|
|||||
|
2015
Q3 | $207K | Buy |
|